Cargando…

Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer

Pancreatic cancer is becoming an increasing healthcare concern. Though it is a 14th most common cancer worldwide, its incidence is steadily rising. Results of currently available therapies are still not satisfactory. Therefore, great attention should be put on the identification and reduction of ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Olakowski, Marek, Bułdak, Łukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394367/
https://www.ncbi.nlm.nih.gov/pubmed/35893093
http://dx.doi.org/10.3390/medicina58080978
_version_ 1784771475337641984
author Olakowski, Marek
Bułdak, Łukasz
author_facet Olakowski, Marek
Bułdak, Łukasz
author_sort Olakowski, Marek
collection PubMed
description Pancreatic cancer is becoming an increasing healthcare concern. Though it is a 14th most common cancer worldwide, its incidence is steadily rising. Results of currently available therapies are still not satisfactory. Therefore, great attention should be put on the identification and reduction of risk factors for pancreatic cancer. A thorough up-to-date review of available data on the impact of well-established and novel risk factors of pancreatic cancer development have been performed. Several risk factors associated with lifestyle have significant impact on the risk of pancreatic cancer (i.e., smoking, obesity, alcohol consumption). Physicians should also be aware of the novel findings suggesting increasing role of microbiome, including viral and bacterial infections, in the development of pancreatic cancer. A growing body of evidence suggest also an increased risk during certain occupational exposures. In general, lifestyle seems to be a major contributor in the development of pancreatic cancer. Special attention should be given to individuals with a vicious cluster consisting of metabolic syndrome, tobacco smoking and alcohol consumption. Physicians should urge patients to comply to healthy diet, cessation of smoking and moderation of alcohol consumption, which may halve pancreatic cancer incidence. Further studies are warranted to explore the potential use of therapeutic approach on novel risk factors (e.g., microbiome).
format Online
Article
Text
id pubmed-9394367
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93943672022-08-23 Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer Olakowski, Marek Bułdak, Łukasz Medicina (Kaunas) Review Pancreatic cancer is becoming an increasing healthcare concern. Though it is a 14th most common cancer worldwide, its incidence is steadily rising. Results of currently available therapies are still not satisfactory. Therefore, great attention should be put on the identification and reduction of risk factors for pancreatic cancer. A thorough up-to-date review of available data on the impact of well-established and novel risk factors of pancreatic cancer development have been performed. Several risk factors associated with lifestyle have significant impact on the risk of pancreatic cancer (i.e., smoking, obesity, alcohol consumption). Physicians should also be aware of the novel findings suggesting increasing role of microbiome, including viral and bacterial infections, in the development of pancreatic cancer. A growing body of evidence suggest also an increased risk during certain occupational exposures. In general, lifestyle seems to be a major contributor in the development of pancreatic cancer. Special attention should be given to individuals with a vicious cluster consisting of metabolic syndrome, tobacco smoking and alcohol consumption. Physicians should urge patients to comply to healthy diet, cessation of smoking and moderation of alcohol consumption, which may halve pancreatic cancer incidence. Further studies are warranted to explore the potential use of therapeutic approach on novel risk factors (e.g., microbiome). MDPI 2022-07-22 /pmc/articles/PMC9394367/ /pubmed/35893093 http://dx.doi.org/10.3390/medicina58080978 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Olakowski, Marek
Bułdak, Łukasz
Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer
title Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer
title_full Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer
title_fullStr Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer
title_full_unstemmed Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer
title_short Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer
title_sort modifiable and non-modifiable risk factors for the development of non-hereditary pancreatic cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394367/
https://www.ncbi.nlm.nih.gov/pubmed/35893093
http://dx.doi.org/10.3390/medicina58080978
work_keys_str_mv AT olakowskimarek modifiableandnonmodifiableriskfactorsforthedevelopmentofnonhereditarypancreaticcancer
AT bułdakłukasz modifiableandnonmodifiableriskfactorsforthedevelopmentofnonhereditarypancreaticcancer